济川药业：本次济川控股解除质押股份的数量为4300万股

Core Viewpoint - Jichuan Pharmaceutical announced the release of 43 million shares from pledge by its controlling shareholder, Jiangsu Jichuan Holding Group, which holds approximately 417 million shares, accounting for 45.27% of the total share capital [1] Company Summary - Jichuan Pharmaceutical's revenue composition for the year 2024 is as follows: 33.53% from heat-clearing and detoxifying products, 28.11% from pediatric products, 14.41% from digestive products, 9.94% from other industries, and 8.13% from respiratory products [1] - As of the report date, Jichuan Pharmaceutical has a market capitalization of 23.6 billion yuan [1]